Mcguire Capital Advisors »

Ptc Therapeutics I shares owned by Mcguire Capital Advisors

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Mcguire Capital Advisors from 13F filings

Historical chart of Mcguire Capital Advisors investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Mcguire Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Mcguire Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $470k 6.9k 68.13
2025-12-31 $397k 5.2k 75.96

More positions owned by Mcguire Capital Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Amazon (AMZN)
Meta Platforms Cl A (META)
Palantir Technologies Cl A (PLTR)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Oneok (OKE)
Alphabet Cap Stk Cl A (GOOGL)
Wal-Mart Stores (WMT)
Caterpillar (CAT)

View all positions for Mcguire Capital Advisors

Top funds holding Ptc Therapeutics I

BlackRock
Rtw Investments
Jupiter Topco
Henderson Group
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Vanguard Capital Management
Geode Capital Management
Toronto-Dominion Bank
Westfield Capital Management Company
Hood River Capital Management
Armistice Capital
William Blair Investment Management
D. E. Shaw & Co

View all funds holding Ptc Therapeutics I